FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2792561369> ?p ?o ?g. }

• W2792561369 endingPage "47" @default.
• W2792561369 startingPage "34" @default.
• W2792561369 abstract "Vincristine is a commonly used chemotherapeutic drug that can produce painful peripheral neuropathy. The chemokine (C-X-C motif) ligand 1 (CXCL1) and its receptor chemokine (C-X-C motif) receptor 2 (CXCR2) may mediate the resolution of this inflammation. In this study, we investigated whether and how CXCL1 contributes to vincristine-induced pain and the underlying mechanisms of levo-corydalmine (l-CDL, a tetrahydroprotoberberine). Oxycodone hydrochloride (a semisynthetic opioid analgesic) was used as positive control in vivo experiments. The results revealed that both l-CDL and oxycodone attenuated vincristine-induced persistent pain hypersensitivity and proinflammatory factors release in mice. CXCL1 and CXCR2 were increased from 6 to 14 days after vincristine administration in the spinal cord. In addition, vincristine injection induced the phosphorylation of NFκB by activating p65/RelA. To confirm these results, we demonstrated that l-CDL controlled astrocytic-released CXCL1 by inhibiting p65/RelA activation, thus acting on the CXCR2 receptor in the spinal cord. In cultured astrocytes, TNF-α elicited marked release of the chemokine CXCL1; moreover, the release was blocked by NFκB p65 small interfering RNA, NFκB inhibitor, and was dose-dependently decreased by l-CDL. However, l-CDL had no effect on CXCL1 in response to NFκB p65-silenced. In primary neurons, l-CDL indirectly reduced an increase in CXCR2 by astrocyte-conditioned medium but did not act directly on the CXCR2 site. Taken together, our data first demonstrate that an NFκB-dependent CXCL1/CXCR2 signaling pathway is involved in vincristine-induced neuropathic pain. In addition, the present findings suggest that l-CDL likely attenuates this inflammation through down-regulation of this signaling pathway." @default.
• W2792561369 created "2018-03-29" @default.
• W2792561369 creator A5002944495 @default.
• W2792561369 creator A5015041062 @default.
• W2792561369 creator A5020248771 @default.
• W2792561369 creator A5021144533 @default.
• W2792561369 creator A5022980110 @default.
• W2792561369 creator A5050345952 @default.
• W2792561369 creator A5058938740 @default.
• W2792561369 creator A5071470503 @default.
• W2792561369 creator A5073659010 @default.
• W2792561369 date "2018-06-01" @default.
• W2792561369 modified "2023-10-03" @default.
• W2792561369 title "Levo-corydalmine alleviates vincristine-induced neuropathic pain in mice by inhibiting an NF-kappa B-dependent CXCL1/CXCR2 signaling pathway" @default.
• W2792561369 cites W1491779415 @default.
• W2792561369 cites W1901316412 @default.
• W2792561369 cites W1935735821 @default.
• W2792561369 cites W1951273690 @default.
• W2792561369 cites W1978459335 @default.
• W2792561369 cites W1979286008 @default.
• W2792561369 cites W1993276142 @default.
• W2792561369 cites W1993285878 @default.
• W2792561369 cites W1995610095 @default.
• W2792561369 cites W2009466572 @default.
• W2792561369 cites W2009784667 @default.
• W2792561369 cites W2021889373 @default.
• W2792561369 cites W2034102455 @default.
• W2792561369 cites W2040157122 @default.
• W2792561369 cites W2040286122 @default.
• W2792561369 cites W2043302657 @default.
• W2792561369 cites W2046221597 @default.
• W2792561369 cites W2047592132 @default.
• W2792561369 cites W2059396054 @default.
• W2792561369 cites W2069024327 @default.
• W2792561369 cites W2071919098 @default.
• W2792561369 cites W2074761018 @default.
• W2792561369 cites W2083432026 @default.
• W2792561369 cites W2088507309 @default.
• W2792561369 cites W2089458218 @default.
• W2792561369 cites W2092460680 @default.
• W2792561369 cites W2094191291 @default.
• W2792561369 cites W2095031669 @default.
• W2792561369 cites W2099991752 @default.
• W2792561369 cites W2103351070 @default.
• W2792561369 cites W2110760372 @default.
• W2792561369 cites W2124997910 @default.
• W2792561369 cites W2137650873 @default.
• W2792561369 cites W2139744978 @default.
• W2792561369 cites W2147597595 @default.
• W2792561369 cites W2148195877 @default.
• W2792561369 cites W2149467065 @default.
• W2792561369 cites W2161514391 @default.
• W2792561369 cites W2161578506 @default.
• W2792561369 cites W2172167484 @default.
• W2792561369 cites W2219371826 @default.
• W2792561369 cites W2221393564 @default.
• W2792561369 cites W2345647689 @default.
• W2792561369 cites W2460275592 @default.
• W2792561369 cites W2478077338 @default.
• W2792561369 cites W2612342004 @default.
• W2792561369 cites W2621034315 @default.
• W2792561369 cites W2622345832 @default.
• W2792561369 cites W293260129 @default.
• W2792561369 cites W563786855 @default.
• W2792561369 doi "https://doi.org/10.1016/j.neuropharm.2018.03.004" @default.
• W2792561369 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29518397" @default.
• W2792561369 hasPublicationYear "2018" @default.
• W2792561369 type Work @default.
• W2792561369 sameAs 2792561369 @default.
• W2792561369 citedByCount "46" @default.
• W2792561369 countsByYear W27925613692018 @default.
• W2792561369 countsByYear W27925613692019 @default.
• W2792561369 countsByYear W27925613692020 @default.
• W2792561369 countsByYear W27925613692021 @default.
• W2792561369 countsByYear W27925613692022 @default.
• W2792561369 countsByYear W27925613692023 @default.
• W2792561369 crossrefType "journal-article" @default.
• W2792561369 hasAuthorship W2792561369A5002944495 @default.
• W2792561369 hasAuthorship W2792561369A5015041062 @default.
• W2792561369 hasAuthorship W2792561369A5020248771 @default.
• W2792561369 hasAuthorship W2792561369A5021144533 @default.
• W2792561369 hasAuthorship W2792561369A5022980110 @default.
• W2792561369 hasAuthorship W2792561369A5050345952 @default.
• W2792561369 hasAuthorship W2792561369A5058938740 @default.
• W2792561369 hasAuthorship W2792561369A5071470503 @default.
• W2792561369 hasAuthorship W2792561369A5073659010 @default.
• W2792561369 hasConcept C126322002 @default.
• W2792561369 hasConcept C12823836 @default.
• W2792561369 hasConcept C13373296 @default.
• W2792561369 hasConcept C170493617 @default.
• W2792561369 hasConcept C185592680 @default.
• W2792561369 hasConcept C2776694085 @default.
• W2792561369 hasConcept C2776755627 @default.
• W2792561369 hasConcept C2777107010 @default.
• W2792561369 hasConcept C2779429289 @default.
• W2792561369 hasConcept C55493867 @default.
• W2792561369 hasConcept C71924100 @default.
• W2792561369 hasConcept C84913492 @default.

• next